Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-08-25
1999-10-26
Mullis, Jeffrey
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A01N 4350
Patent
active
059729481
ABSTRACT:
A method of using moxonidine or a physiologically acceptable acid addition salt thereof for the treatment and/or prophylaxis of glucose metabolism disorders such as insulin resistance and/or glucose intolerance, and pharmaceutical compositions for use therein.
REFERENCES:
patent: 4323570 (1982-04-01), Stenzel et al.
patent: 5296498 (1994-03-01), Malen et al.
patent: 5494934 (1996-02-01), Malen et al.
patent: 5574059 (1996-11-01), Regunathan et al.
patent: 5795909 (1998-08-01), Shashoua et al.
Muller et al., "Steady State Investigation of Possible Pharmacokinetic Interactions of Moxonodine and Glibenclamide", European Journal of Metabolism and Pharmacokinetics, 1993, vol. 18, No. 3, pp. 277-283.
Schwarz et al., "Langzeiterfahrungen mit Monoxnoidin, einem neuen Antihypertensivum", Fortschr. Med. 108 (1990), No. 32, pp. 616-620.
Rupp et al., "Modification of Myosin Isozymes and SR Ca.sup.2+ -pump ATPase of the Diabetic Rat . . . ", Molecular and Cellular Biology, 132:69-80 (1994).
Michel et al., "From .alpha..sub.2 -Adrenoceptors to Imidazoline Receptors: Putative Progress fro Cardiovascular Therapy", Journal of Cardiovascular Pharmacology, 20 (Suppl. 4): S24-S30 (1992).
Rupp et al., Therapiewoche, vol. 43, No. 32/33, pp. 1686-93 (1993).
Dotzer et al., Z. Allg. Med., 68:760-763 (1992).
Trieb et al., "Wirksamkeit und Vertraeglichkeit des Imidazol-Receptor-Agonisten", Therapiestudien, 1994, 45: 440-45.
Brueckner Reinhard
Kaan Elbert
Ziegler Dieter
Mullis Jeffrey
Solvay Pharmaceuticals GmbH
LandOfFree
Method of inhibiting hyperglycemia and pharmaceutical compositio does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inhibiting hyperglycemia and pharmaceutical compositio, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inhibiting hyperglycemia and pharmaceutical compositio will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764856